1. Exploration of a panel of urine biomarkers of kidney disease in two paediatric cohorts with Type 1 diabetes mellitus of differing duration
- Author
-
Letizia Zeni, Anthony G. W. Norden, Elena Prandi, Carolina Canepa, Keith Burling, Katherine Simpson, Barbara Felappi, Alessandro Plebani, Giovanni Cancarini, Pietro Manuel Ferraro, Donald Fraser, Robert J. Unwin, Zeni, Letizia [0000-0001-9221-5698], and Apollo - University of Cambridge Repository
- Subjects
Research ,Endocrinology, Diabetes and Metabolism ,Urinary biomarkers ,Internal Medicine ,Albuminuria ,Type 1 diabetes mellitus ,Urine free retinol-binding protein 4 ,Diabetic kidney disease ,Kidney injury molecule-1 ,microRNAs - Abstract
Background The pathogenesis of diabetic kidney disease (DKD) is complex and involves both glomerular and tubular dysfunction. A global assessment of kidney function is necessary to stage DKD, a progressive kidney disease that is likely to begin in childhood. The present study evaluated whether kidney injury biomarkers identified as early DKD biomarkers in adults have any prognostic value in the very early stages of childhood diabetes. Methods We measured urine free Retinol-binding protein 4 (UfRBP4), albumin (UAlb), Kidney injury molecule-1 (KIM-1) and the microRNAs miR-155, miR-126 and miR-29b in two cohorts of paediatric T1DM patients without evidence of DKD, but with diabetes of short-duration, ≤ 2.5 years (SD, n = 25) or of long-duration, ≥ 10 years (LD, n = 29); non-diabetic siblings (H, n = 26) were recruited as controls. A p value Results UfRBP4 and UAlb were not significantly different across the three groups. No differences were found in KIM-1 excretion between any of the three groups. UfRBP4 was correlated with UAlb in all three groups (r 0.49; p Conclusions UfRBP4, KIM-1, miR-155, and miR-126 were unaffected by the presence and duration of diabetes, whereas miR-29b showed a modest elevation in diabetics, regardless of duration. These data support the specificity of a panel of urine biomarkers as DKD biomarkers, rather than any relationship to diabetes per se or its duration, and not as early DKD biomarkers in a paediatric setting.
- Published
- 2022